Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2012-02-01
2016-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
NCT05085223
Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit
NCT03752450
Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar Hyponatremia
NCT00541944
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
NCT04043598
Mortality and Neurologic Outcomes in Rapid vs. Slow Hyponatremia Correction
NCT06675591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
traumatic brain injury
No interventions assigned to this group
aneurysmal subarachnoid hemorrhage
No interventions assigned to this group
intracerebral hematoma
No interventions assigned to this group
brain tumor
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to an intensive care unit for more than 48 hours
* ICD-9 codes for aneurysmal SAH, TBI, IPH, or intracranial tumor.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma Inc
INDUSTRY
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Theresa Human-Murphy
Pharm.D., BCPS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gretchen Brophy, Pharm.D
Role: PRINCIPAL_INVESTIGATOR
VCU
Theresa Murphy-Human, Pharm.D.
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Hospital
Hartford, Connecticut, United States
Yale-New Haven Hospital
New Haven, Connecticut, United States
Jackson Memorial Hospital
Miami, Florida, United States
Memorial University Medical Center
Savannah, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Via Christi Hospital
Wichita, Kansas, United States
UK Healthcare
Lexington, Kentucky, United States
The Johns Hopkins hospital
Baltimore, Maryland, United States
Detroit Receiving Hospital
Detroit, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
St Louis University Hospital
St Louis, Missouri, United States
Washington University
St Louis, Missouri, United States
Columbia University
New York, New York, United States
UC Health -University Hospital
Cincinnati, Ohio, United States
University of Tennessee
Knoxville, Tennessee, United States
University of Virginial Health System
Charlottesville, Virginia, United States
Virginial Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201203034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.